Cadila Healthcare informs about press release

29 Mar 2019 Evaluate

Cadila Healthcare has informed about submission of a copy of press release dated March 29, 2019 titled ‘Zydus receives final approval from the USFDA for Ambrisentan Tablets’. The contents of the press release give full details.

The above information is a part of company’s filings submitted to BSE.

Zydus Lifesciences Share Price

1001.85 16.30 (1.65%)
31-Oct-2024 16:01 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1849.05
Dr. Reddys Lab 1274.25
Cipla 1553.20
Lupin 2184.00
Zydus Lifesciences 1001.85
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.